About
Glytec eGlycemic, now unified under the GlytecOne platform, is a comprehensive AI-powered glycemic management solution purpose-built for hospitals and health systems. At its core is Glucommander®, an FDA-cleared insulin dosing engine that replaces high-risk manual protocols with evidence-based, real-time dosing guidance to reduce hypoglycemia and hyperglycemia events. GlytecOne integrates four key pillars: Care Enablement (standardized clinical workflows and insulin dosing guidance), Decision Support (patient visibility and structured clinical review via a Command Center), Performance Insights (enterprise analytics, benchmarking, and CMS eCQM-aligned reporting), and Population Health (enterprise-wide glycemic intelligence for health system leaders). With over 400 hospital clients, 100+ patents, and 50 billion data points processed over 16 years, Glytec has a well-established clinical evidence base. Documented outcomes include a 99.8% reduction in inpatient hypoglycemia, 68% reduction in 30-day readmissions, 47% nurse time savings, and a 6–8x ROI for hospital partners. GlytecOne is particularly relevant for organizations preparing for the 2026 CMS severe hypoglycemia and hyperglycemia eCQM reporting mandate. The platform integrates with major EHR systems, enabling seamless adoption into existing clinical workflows. It is ideal for clinical leadership, CMIOs, CIOs, pharmacy leaders, and frontline providers and nurses seeking to standardize and improve glycemic care at scale.
Key Features
- FDA-Cleared Insulin Dosing (Glucommander®): Provides real-time, evidence-based insulin dosing recommendations that replace high-risk manual protocols, reducing severe hypoglycemia and hyperglycemia events.
- Clinical Decision Support Command Center: Gives care teams a real-time view of all glycemic patients, enabling structured clinical review and proactive intervention before harm occurs.
- CMS eCQM Compliance Reporting: Enterprise analytics and benchmarking tools aligned to CMS severe hypoglycemia and hyperglycemia eCQM measures, helping hospitals meet the 2026 mandatory reporting period.
- Population Health & Enterprise Intelligence: System-wide glycemic data visibility for health system leaders and health plan partners to drive strategic improvements across the entire patient population.
- EHR Integration: Seamlessly connects with major electronic health record systems to embed glycemic guidance and analytics directly into existing clinical workflows.
Use Cases
- Automating insulin dosing protocols across hospital inpatient units to eliminate high-risk manual titration
- Preparing for and complying with the 2026 CMS severe hypoglycemia and hyperglycemia eCQM reporting mandate
- Providing ICU and medical-surgical nurses with real-time dosing guidance to reduce cognitive burden and save time per shift
- Enabling health system executives to monitor and benchmark glycemic performance enterprise-wide through population health dashboards
- Reducing hospital costs associated with severe hypoglycemia events and preventable 30-day readmissions in diabetic patients
Pros
- FDA-Cleared & Clinically Validated: Glucommander® is FDA-cleared and backed by 50 billion data points and 16 years of real-world outcomes, providing hospitals with a trusted, evidence-based foundation.
- Proven Financial and Clinical ROI: Clients report 6–8x ROI, $10k+ average cost savings per severe hypoglycemia event, and up to 99.8% reduction in inpatient hypoglycemia incidents.
- End-to-End Glycemic Platform: A single unified solution covering bedside dosing guidance, workflow automation, analytics, and population health — eliminating the need for multiple disjointed tools.
- CMS eCQM Readiness Support: Built-in reporting and guidance specifically designed to help hospitals comply with the 2026 CMS glycemic harm eCQM mandate.
Cons
- Hospital & Health System Only: GlytecOne is purpose-built for inpatient hospital settings and is not applicable to outpatient clinics, private practices, or individual diabetes management.
- Enterprise Pricing: As a specialized SaaS platform for large healthcare organizations, costs are significant and likely prohibitive for smaller or resource-limited facilities.
- Implementation Complexity: EHR integrations and clinical workflow standardization require significant onboarding effort and coordination across IT, pharmacy, and clinical teams.
Frequently Asked Questions
What is GlytecOne and how does it differ from the eGlycemic Management System?
GlytecOne is Glytec's unified platform that consolidates its previous eGlycemic Management System capabilities — including Glucommander® — into a single solution covering care enablement, decision support, performance insights, and population health management.
Is Glucommander® FDA-cleared?
Yes. Glucommander® is FDA-cleared for insulin dosing guidance. It is the core clinical engine of the GlytecOne platform and has been used across 400+ hospital clients over 16 years.
How does Glytec help hospitals prepare for the 2026 CMS eCQM mandate?
GlytecOne includes analytics and reporting tools specifically aligned to the CMS severe hypoglycemia and hyperglycemia hospital harm eCQMs, helping hospitals measure, track, and report glycemic outcomes during the active 2026 measurement period.
What EHR systems does GlytecOne integrate with?
Glytec offers EHR integrations as part of the GlytecOne platform. Specific EHR compatibility details are available upon request during a product demo, as integrations are tailored to each hospital's existing infrastructure.
What clinical outcomes can hospitals expect from GlytecOne?
Hospitals using GlytecOne have reported a 99.8% reduction in inpatient hypoglycemia, 3.1% reduction in A1C, up to 68% reduction in 30-day readmissions, and up to 47% nurse time savings per shift spent on glycemic management tasks.
